跳至主要内容
临床试验/NCT00543270
NCT00543270已完成不适用

Endologix Powerlink Long-Term Follow-up Study

Endologix14 个研究点 分布在 1 个国家目标入组 258 人开始时间: 2005年10月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
已完成
发起方
Endologix
入组人数
258
试验地点
14
主要终点
All Cause Mortality

研究概览

简要总结

Endologix Infrarenal Bifurcated Stent Graft Study

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •All surviving patients from the original study cohort who received the Powerlink device
  • •All surviving patients from the original study cohort who were assigned to the open surgical control arm

排除标准

  • 未提供

研究组 & 干预措施

Endovascular Repair - EVAR (Powerlink System)

Experimental

EVAR (Powerlink System)

干预措施: Powerlink infrarenal bifurcated stent graft delivery system (Device)

Open Surgical Control

Active Comparator

Open Surgical Control

干预措施: Open Surgery (Procedure)

结局指标

主要结局

All Cause Mortality

时间窗: At 1 Year

No of deaths reported through 1 year

No of Subjects with Major adverse events

时间窗: At 1 Year

Aneurysm-related mortality, aneurysm rupture, conversion to open repair, coronary intervention, myocardial infarction, renal failure, respiratory failure, secondary procedure, and stroke

次要结局

  • Aneurysm Morphology(Year 5)
  • Clinical Utility Outcomes(up to 1 week)
  • Stent Graft Performance(Year 5)
  • Stent Graft Performance(30 Days)
  • Stent Graft Performance(6 Months)
  • Stent Graft Performance(Year 1)
  • Stent Graft Performance(Year 2)
  • Stent Graft Performance(Year 3)
  • Stent Graft Performance(Year 4)
  • Clinical Utility Outcomes(During the Procedure)
  • Aneurysm Morphology(6 Months)
  • Aneurysm Morphology(Year 1)
  • Aneurysm Morphology(Year 2)
  • Aneurysm Morphology(Year 3)
  • Aneurysm Morphology(Year 4)

研究者

发起方
Endologix
申办方类型
Industry
责任方
Sponsor

研究点 (14)

Loading locations...

相似试验